Giovanni Loureiro Raspantini

Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Abstract
Prostate cancer is the second most incident type of cancer among men. Only in Brazil, 61.200 new cases are expected to be diagnosed in 2016. Though a huge progress has been observed on the prostate cancer treatment over the last few decades, this pathology keeps being the second highest cause of deaths related to cancer among men. Regarding the indicated drugs for the treatment of this p…
e-polycaprolactone and D-±-tocopherol polyethylene glycol-1000 nanoparticles containing docetaxel aiming prostate cancer therapy, BP.MS
Abstract
Breast Cancer is a disease with considerable impact on the world population and the search for alternative therapies for its treatment is a necessity of contemporary medicine. Moreover, this condition is not presented as a single entity but rather divided into subtypes characterized by the presence or absence of certain molecular markers - thus requiring the use of different targeted ther…
Preparação e caracterização de lipossomas contendo metformina: um potencial sistema de liberação para o tratamento do câncer de mama, BP.IC

Source:Lattes Curriculum

CV Lattes ResearcherID

2 / 2	Completed scholarships in Brazil

Associated processes

Short URL

Abstract

Abstract